Puma Biotechnology (PBYI) Other Operating Expenses (2011 - 2026)

Puma Biotechnology has reported Other Operating Expenses for 12 years, with the latest figure at $10.4 million in Q1 2026.

• For the quarter ending Q1 2026, Other Operating Expenses fell 1.25% year-over-year to $10.4 million; the trailing twelve-month figure through Mar 2026 stood at $58.0 million (down 9.66% YoY), and the FY2025 full-year result was $58.2 million, down 9.7% from the prior year.
• Other Operating Expenses for Q1 2026 stood at $10.4 million, down from $23.1 million in the prior quarter.
• The five-year high for Other Operating Expenses was $29.1 million in Q3 2024, with the low at $10.4 million in Q1 2026.
• Historically, Other Operating Expenses has averaged $15.4 million across 5 years, with a median of $13.2 million in 2023.
• The largest YoY upside for Other Operating Expenses was 131.03% in 2022 against a maximum downside of 63.31% in 2022.
• Puma Biotechnology's Other Operating Expenses stood at $16.8 million in 2022, then surged by 44.47% to $24.3 million in 2023, then plunged by 42.77% to $13.9 million in 2024, then soared by 66.13% to $23.1 million in 2025, then sank by 54.93% to $10.4 million in 2026.
• The last three Other Operating Expenses figures came in at $10.4 million (Q1 2026), $23.1 million (Q4 2025), and $12.2 million (Q3 2025), per Business Quant data.